Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader https://ift.tt/2G8eXt4
via IFTTT